Constipation Treatment Market Top Players- AbbVie's Inc.; Takeda Pharmaceutical Company Limited; Bausch Health Companies Inc.

According to our new market research study on “Constipation Treatment Market to 2027 – Global Analysis and Forecast – by Therapeutic, Disease, and Distribution Channel,” the market is expected to reach US$ 13,386.19 million by 2027 from US$ 8,533.89 million in 2019; it is estimated to grow at a CAGR of 5.9% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. The key factors driving the market growth include the rising prevalence of chronic constipation and increasing number of FDA approvals and drug developments drive the market growth. However, preference for home and herbal remedies hinder the market growth.
Request Sample Copy Of this Report @ http://bit.ly/37rcmey

Based on therapeutic, the constipation treatment market is segmented into laxatives, chloride channel activators, peripherally acting mu-opioid receptor antagonists, GC-C agonists, and 5-HT4 receptor agonists. The laxatives segment held the largest share of the market in 2019. However, GC-C agonists segment is anticipated to register the highest in the market during the forecast period. The growth of GC-C agonists is expected to grow at fastest growth rate due to rising product developments and product launches in the market.
The report segments global constipation treatment market as follows:

By Therapeutic
• Laxatives
• Chloride Channel Activators
• Peripherally Acting Mu-Opioid Receptor Antagonists
• GC-C Agonists
• 5-HT4 Receptor Agonists
By Disease
• Chronic Idiopathic Constipation
• Irritable Bowel Syndrome With Constipation
• Opioid-Induced Constipation
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Constipation is a commonly seen health condition among all age groups across the world. According to the article ‘Chronic Constipation’ published in May 2018, worldwide, the prevalence of constipation is estimated to be 16%. It is estimated to be varying between 0.7% to 79%. Also, the prevalence of constipation is higher among people age 60 years and above. The attributed prevalence of constipation to this age group is 33.5%.
Several factors are associated with the rising prevalence among older people, which include lack of normal bowel movements due to progressive age, improper diet and fluid intake, and inadequate physical activity. Whereas, among adults, the common cause of constipation is stress, lack of exercise, endocrine disorders, colon diseases, neurological dysfunction, and other causes such as environmental and pharmaceutical conditions.
Purchase Copy of this Report @ http://bit.ly/3mxzzQx
The prevalence of constipation across the world varies substantially due to the different ethnic groups and perceptions. For instance, according to the article ‘What is the worldwide prevalence of constipation?’ published in March 2020, in North America, ~63 million people are affected by chronic constipation. Likewise, ~12% of people across the world live with self-defined constipation. The data also stated that people in the Americas and the Asia Pacific the prevalence is twice the European region. Constipation causes psychological morbidity and results in low quality of life. Thus, it essential to diagnose, manage, and treat constipation is very important. Therefore, the rising prevalence of constipation is expected to drive the demand for medicines treating constipation, further lead to the growth of the market.

Contact:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

This release was published on openPR.